These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151 [TBL] [Abstract][Full Text] [Related]
26. Clopidogrel-drug interactions. Bates ER; Lau WC; Angiolillo DJ J Am Coll Cardiol; 2011 Mar; 57(11):1251-63. PubMed ID: 21392639 [TBL] [Abstract][Full Text] [Related]
27. The need for translational research on drug-drug interactions. Hennessy S; Flockhart DA Clin Pharmacol Ther; 2012 May; 91(5):771-3. PubMed ID: 22513312 [TBL] [Abstract][Full Text] [Related]
28. Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone. Itkonen MK; Tornio A; Neuvonen M; Neuvonen PJ; Niemi M; Backman JT Drug Metab Dispos; 2016 Aug; 44(8):1364-71. PubMed ID: 27260150 [TBL] [Abstract][Full Text] [Related]
29. Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes. Wang JS; Neuvonen M; Wen X; Backman JT; Neuvonen PJ Drug Metab Dispos; 2002 Dec; 30(12):1352-6. PubMed ID: 12433802 [TBL] [Abstract][Full Text] [Related]
30. Clopidogrel-statin interaction: myth or reality? Angiolillo DJ; Alfonso F J Am Coll Cardiol; 2007 Jul; 50(4):296-8. PubMed ID: 17659195 [No Abstract] [Full Text] [Related]
31. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203 [TBL] [Abstract][Full Text] [Related]
32. Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. Hagihara K; Nishiya Y; Kurihara A; Kazui M; Farid NA; Ikeda T Drug Metab Pharmacokinet; 2008; 23(6):412-20. PubMed ID: 19122335 [TBL] [Abstract][Full Text] [Related]
33. Bayer's response to "potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis". Piorkowski JD JAMA; 2004 Dec; 292(21):2655-7; discussion 2658-9. PubMed ID: 15572725 [No Abstract] [Full Text] [Related]
34. Possible mechanisms of drug-induced aspirin and clopidogrel resistance. Schroeder WS; Ghobrial L; Gandhi PJ J Thromb Thrombolysis; 2006 Oct; 22(2):139-50. PubMed ID: 17008981 [TBL] [Abstract][Full Text] [Related]
35. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Lau WC; Waskell LA; Watkins PB; Neer CJ; Horowitz K; Hopp AS; Tait AR; Carville DG; Guyer KE; Bates ER Circulation; 2003 Jan; 107(1):32-7. PubMed ID: 12515739 [TBL] [Abstract][Full Text] [Related]
36. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil]. Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824 [TBL] [Abstract][Full Text] [Related]
37. Clarification of the Mechanism of Clopidogrel-Mediated Drug-Drug Interaction in a Clinical Cassette Small-dose Study and Its Prediction Based on In Vitro Information. Kim SJ; Yoshikado T; Ieiri I; Maeda K; Kimura M; Irie S; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2016 Oct; 44(10):1622-32. PubMed ID: 27457785 [TBL] [Abstract][Full Text] [Related]